acridines has been researched along with Breast Neoplasms in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (20.93) | 18.7374 |
1990's | 4 (9.30) | 18.2507 |
2000's | 11 (25.58) | 29.6817 |
2010's | 16 (37.21) | 24.3611 |
2020's | 3 (6.98) | 2.80 |
Authors | Studies |
---|---|
Dokala, A; Gurrapu, N; Kolluri, PK; Praveenkumar, E; Subhashini, NJP | 1 |
Aparna, B; Byran, G; Emran, TB; Gonçalves Lima, CM; Nafady, MH; Rajagopal, K; Raman, K; Rashid, S; Varakumar, P; Wybraniec, S | 1 |
AlSultan, D; Castell, A; Crown, J; Duffy, MJ; Eustace, AJ; Kavanagh, E; Larsson, LG; Madden, SF; O'Grady, S | 1 |
Fujita, KI; Kato, Y; Kubota, Y; Masuo, Y; Nakamichi, N; Sasaki, Y; Shibutani, T; Yamazaki, E | 1 |
Chiorazzo, MG; Delikatny, EJ; Johansen, B; Moestue, S; Popov, AV; Tunset, HM | 1 |
Argyri, SM; Chatgilialoglu, C; Dousi, I; Efthimiadou, EK; Kellett, A; Kokoli, M; Krokidis, MG; Masi, A; Molphy, Z; Papadopoulos, K | 1 |
Bhatt, HG; Chaube, UJ; Chhatbar, DM; Vyas, VK | 1 |
Bierbach, U; Ding, S; Kucera, GL; Qiao, X | 1 |
Chen, KM; Chen, KY; Kwon, CH; Sun, YW | 1 |
Bernish, BW; Bierbach, U; Ding, S; Donati, GL; Fahrenholtz, CD; Gross, MD; Singh, R; Wright, ML; Yang, M; Yao, X; Zheng, Y | 1 |
Alves, LC; Beltrão, EIC; Brayner, FA; da Silva, LPBG; de Almeida, SMV; de Carvalho Júnior, LB; de Carvalho, JE; de Lima, LRA; de Lima, MDCA; Longato, GB; Padilha, RJR; Ruiz, ALTG | 1 |
Almeida, SMV; Beltrão, EIC; Botelho, SPS; Carvalho Júnior, LB; Lima, LRA; Lima, MDC; Pitta, IDR; Silva, LPBG | 1 |
Bekaii-Saab, T; Kraut, EH; Kuebler, JP; Mrozek, E; Ramaswamy, B | 1 |
Arnaud, O; Bates, SE; Boumendjel, A; Di Pietro, A; Dumontet, C; Falson, P; Gèze, A; Guitton, J; Honorat, M; Matera, EL; Payen, L; Stein, WD | 1 |
Komina, O; Maurer, M; Składanowski, A; Wesierska-Gadek, J | 1 |
Wang, XD; Zeng, S | 1 |
Bankstahl, JP; Bankstahl, M; Bauer, F; Chiba, P; Dörner, B; Erker, T; Kuntner, C; Langer, O; Löscher, W; Mairinger, S; Miller, DW; Müllauer, J; Müller, M; Stanek, J; Wanek, T | 1 |
Bankstahl, JP; Bankstahl, M; Erker, T; Kuntner, C; Langer, O; Löscher, W; Mairinger, S; Müller, M; Sauberer, M; Stanek, J; Strommer, S; Wacheck, V; Wanek, T | 1 |
Ferk, F; Komina, O; Maurer, M; Składanowski, A; Węsierska-Gądek, J; Zulehner, N | 1 |
Boven, E; Hoogsteen, IJ; Kohlhagen, G; Maliepaard, M; Pinedo, HM; Pommier, Y; Scheffer, GL; Scheper, RJ; Schlüper, HM; van Hattum, AH | 1 |
LUCENA, CM; ORSINI, W; ROGANTI, A | 1 |
Herrmann, A; Lage, H; Osada, H; Woehlecke, H | 1 |
Ejendal, KF; Hrycyna, CA | 1 |
Bendayan, R; Rauth, AM; Wong, HL; Wu, XY | 1 |
Ahmed-Belkacem, A; Blanc, M; Boumendjel, A; Di Pietro, A; Macalou, S | 1 |
Azzariti, A; Berardi, F; Cantore, M; Colabufo, NA; Contino, M; Inglese, C; Niso, M; Paradiso, A; Perrone, MG; Perrone, R; Porcelli, L; Simone, GM | 1 |
Du Vignaud, P; Grand-Perret, T; Hyafil, F; Vergely, C | 1 |
Allegra, CJ; Balis, FM; Benchekroun, NM; Berg, SL; Dahut, W; Grem, JL; Patel, M; Politi, PM; Sinha, BK | 1 |
Ashizawa, T; Gomi, K; Okabe, M; Shimizu, M | 1 |
Ballinger, JR; Moore, MJ; Muzzammil, T | 1 |
Carmichael, J; Ellis, MJ; Hagan, DJ; Hammonds, TR; Stanslas, J; Stevens, MF; Turner, C; Ward, W | 1 |
Beijnen, JH; Jewell, RC; Koopman, FJ; Malingré, MM; Paul, EM; Rosing, H; Schellens, JH; Ten Bokkel Huinink, WW | 1 |
Aktan, AO; Haklar, G; Sayin-Ozveri, E; Yalçin, AS; Yüksel, M | 1 |
Hudes, G | 1 |
Beijnen, JH; Jewell, RC; Kruijtzer, CM; Paul, EM; Rosing, H; Schellens, JH; Schot, M; ten Bokkel Huinink, WW | 1 |
Choksey, AF; Jussawalla, DJ; Sirsat, SM | 1 |
Arnaboldi, A; Bianchi, A; Daffara, P; Santamaria, L | 1 |
Krawczyk, K; Pawlicki, M | 1 |
Adams, LR; Kamentsky, LA; Melamed, MR; Traganos, F; Zimring, A | 1 |
Sümegi, I | 1 |
Knorre, D | 1 |
Swiecki, J; Wieczorkiewicz, A | 1 |
Panecka, A | 1 |
1 review(s) available for acridines and Breast Neoplasms
Article | Year |
---|---|
Acridine as an Anti-Tumour Agent: A Critical Review.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Line, Tumor; DNA; Female; Humans; Intercalating Agents | 2022 |
3 trial(s) available for acridines and Breast Neoplasms
Article | Year |
---|---|
Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer.
Topics: Acridines; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Demography; Female; Humans; Middle Aged; Neoplasm Metastasis; Pyrazoles; Treatment Outcome | 2011 |
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients.
Topics: Acridines; Administration, Oral; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Humans; Infusions, Intravenous; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Tetrahydroisoquinolines | 2001 |
Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.
Topics: Acridines; Administration, Oral; Adult; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Availability; Breast Neoplasms; Drug Administration Schedule; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Isoquinolines; Middle Aged; Neoplasm Proteins; Tetrahydroisoquinolines; Topotecan | 2002 |
39 other study(ies) available for acridines and Breast Neoplasms
Article | Year |
---|---|
Selective CDK4/6 inhibition of novel 1,2,3-triazole tethered acridinedione derivatives induces G1/S cell cycle transition arrest via Rb phosphorylation blockade in breast cancer models.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Dose-Response Relationship, Drug; Female; Humans; Models, Molecular; Molecular Structure; Phosphorylation; Protein Kinase Inhibitors; Retinoblastoma; Structure-Activity Relationship; Triazoles | 2021 |
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells.
Topics: Acridines; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Inhibitory Concentration 50; Molecular Weight; Pyridines; RNA, Messenger | 2021 |
Involvement of the Transporters P-Glycoprotein and Breast Cancer Resistance Protein in Dermal Distribution of the Multikinase Inhibitor Regorafenib and Its Active Metabolites.
Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Diketopiperazines; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mice; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Skin; Tetrahydroisoquinolines; Tissue Distribution | 2017 |
Detection and Differentiation of Breast Cancer Sub-Types using a cPLA2α Activatable Fluorophore.
Topics: Acridines; Administration, Topical; Animals; Arachidonic Acid; Breast Neoplasms; Contrast Media; Female; Fluorescent Dyes; Group IV Phospholipases A2; Humans; Injections, Intraperitoneal; Mammary Glands, Animal; Mastectomy; MCF-7 Cells; Mice; Optical Imaging; Video-Assisted Surgery; Xenograft Model Antitumor Assays | 2019 |
Assessment of DNA Topoisomerase I Unwinding Activity, Radical Scavenging Capacity, and Inhibition of Breast Cancer Cell Viability of
Topics: Acridines; Acridones; Benzothiazoles; Biphenyl Compounds; Breast Neoplasms; Cell Survival; DNA; DNA Topoisomerases, Type I; Female; Free Radical Scavengers; Humans; MCF-7 Cells; Picrates; Sulfonic Acids; Wound Healing | 2019 |
CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Topics: Acridines; Binding Sites; Breast Neoplasms; Datasets as Topic; Drug Design; Humans; Hydrogen Bonding; Least-Squares Analysis; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Morpholines; Protein Binding; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; TOR Serine-Threonine Kinases; Triazines | 2019 |
Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer.
Topics: Acridines; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; DNA; Drug Design; Female; Humans; Intercalating Agents; MCF-7 Cells; Platinum; Receptors, Estrogen; Tamoxifen | 2013 |
CK0403, a 9‑aminoacridine, is a potent anti‑cancer agent in human breast cancer cells.
Topics: Acridines; Apoptosis; Autophagy-Related Protein 5; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Microtubule-Associated Proteins; Receptor, ErbB-2; Sulfides | 2016 |
Design and cellular studies of a carbon nanotube-based delivery system for a hybrid platinum-acridine anticancer agent.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Hyperthermia, Induced; Nanotubes, Carbon; Phototherapy; Platinum | 2016 |
Ultrastructural Assessment of 2-(acridin-9-ylmethylene)-N-phenylhydrazinecarbothioamide activity on human breast adenocarcinoma cells.
Topics: Acridines; Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Cell Proliferation; Cell Survival; DNA Fragmentation; Female; Humans; MCF-7 Cells; Microscopy, Electron, Scanning; Phosphatidylserines | 2016 |
Dimethyl-2-[(acridin-9-yl)methylidene]-malonate as fluorescent probe for histochemical analysis.
Topics: Acridines; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Circular Dichroism; Concanavalin A; Female; Fibroadenoma; Fluorescence; Fluorescent Dyes; Humans; Lectins; Malonates | 2017 |
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan.
Topics: Acridines; Acridones; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Camptothecin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; HEK293 Cells; Humans; Irinotecan; Mice; Mice, SCID; Neoplasm Proteins; Neoplasm Transplantation; Transplantation, Heterologous | 2011 |
Triazoloacridone C-1305 abrogates the restriction checkpoint in cells lacking functional p53 and promotes their accumulation in the G2/M phase of the cell cycle.
Topics: Acridines; Breast Neoplasms; Cyclin-Dependent Kinase 2; Female; G2 Phase; HL-60 Cells; Humans; Immunoblotting; Phosphorylation; Topoisomerase II Inhibitors; Triazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2011 |
The transport of gastrodin in Caco-2 cells and uptake in Bcap37 and Bcap37/MDR1 cells.
Topics: Acridines; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzyl Alcohols; Biological Transport; Blood-Brain Barrier; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Drug Resistance, Multiple; Gastrodia; Glucosides; Humans; Plants, Medicinal; Prohibitins; Rhodamine 123; Tetrahydroisoquinolines; Verapamil | 2010 |
Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance protein.
Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Breast Neoplasms; Drug Resistance, Multiple; Female; Fluorine Radioisotopes; Humans; Isotope Labeling; Mice; Models, Molecular; Neoplasm Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Tissue Distribution | 2011 |
A comparative small-animal PET evaluation of [11C]tariquidar, [11C]elacridar and (R)-[11C]verapamil for detection of P-glycoprotein-expressing murine breast cancer.
Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Carbon Radioisotopes; Cell Line, Tumor; Disease Models, Animal; Doxorubicin; Drug Resistance, Neoplasm; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Mice; Phenotype; Positron-Emission Tomography; Quinolines; Tetrahydroisoquinolines; Verapamil | 2012 |
PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells.
Topics: Acridines; Antineoplastic Agents; Apoptosis; BRCA1 Protein; Breast Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Breaks; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Topoisomerase II Inhibitors; Triazoles; Tumor Suppressor Protein p53 | 2012 |
Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity.
Topics: Acridines; Animals; Antigens, CD; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Camptothecin; Cell Division; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Female; Humans; Immunoenzyme Techniques; Isoquinolines; Membrane Glycoproteins; Mice; Mice, Nude; Mutation; Neoplasm Proteins; Neoplasms, Experimental; Ovarian Neoplasms; Tetrahydroisoquinolines; Tetraspanin 29; Tetrazolium Salts; Thiazoles; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2002 |
[BIOPSY FOR FREEZING AND FLUOROMICROSCOPY WITH ACRIDINE ORANGE. (COMPARATIVE STUDY IN BREAST TUMORS)].
Topics: Acridine Orange; Acridines; Adolescent; Biopsy; Breast Neoplasms; Fluorescence; Fluorescent Dyes; Freezing; Geriatrics; Humans; Microscopy; Microscopy, Fluorescence | 1964 |
Reversal of breast cancer resistance protein-mediated drug resistance by tryprostatin A.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Cell Division; Daunorubicin; Drug Resistance, Multiple; Female; Humans; Indole Alkaloids; Kinetics; Mitoxantrone; Piperazines; Stomach Neoplasms; Tetrahydroisoquinolines; Tumor Cells, Cultured | 2003 |
Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A.
Topics: Acridines; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Cyclosporine; Female; HeLa Cells; Humans; Intracellular Membranes; Kinetics; Microsomes; Neoplasm Proteins; Recombinant Proteins; Substrate Specificity; Tetrahydroisoquinolines; Transfection | 2005 |
Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Doxorubicin; Drug Carriers; Drug Combinations; Drug Compounding; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Lipids; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polymers; Surface Properties; Tetrahydroisoquinolines | 2006 |
Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2.
Topics: Acridines; Acridones; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Catalysis; Cell Line, Tumor; Cyclization; Drug Design; Drug Resistance, Neoplasm; Female; Flow Cytometry; Genes, MDR; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mitoxantrone; Neoplasm Proteins; Spectrometry, Fluorescence; Structure-Activity Relationship | 2007 |
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
Topics: Acridines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Female; Humans; Isoquinolines; Ligands; Quinolines; Structure-Activity Relationship; Tetrahydroisoquinolines | 2008 |
In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.
Topics: Acridines; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Colonic Neoplasms; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Female; Humans; Isoquinolines; Leukemia P388; Mice; Mice, Inbred DBA; Ovary; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1993 |
Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cells.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Count; DNA; Dose-Response Relationship, Drug; Electrophoresis; Female; Humans; Pyrazoles; Time Factors | 1996 |
Antitumor activity of KW-2170, a novel pyrazoloacridone derivative.
Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Doxorubicin; Drug Resistance, Multiple; Female; Fibrosarcoma; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Molecular Structure; Neoplasms; Prostatic Neoplasms; Pyrazoles; Sarcoma 180; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
99Tcm-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer.
Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Isoquinolines; Mammary Neoplasms, Animal; Mice; Mice, SCID; Neoplasm Transplantation; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tetrahydroisoquinolines; Transplantation, Heterologous | 1999 |
Antitumor polycyclic acridines. 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridines.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Inhibitory Concentration 50; Lung Neoplasms; Microscopy, Fluorescence; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2000 |
Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors.
Topics: Acridines; Adult; Aged; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Hypochlorous Acid; Luminescent Measurements; Luminol; Male; Middle Aged; Nitrates; Nitric Oxide; Reactive Oxygen Species | 2001 |
Boosting bioavailability of topotecan: what do we gain?
Topics: Acridines; Administration, Oral; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Availability; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Intestinal Absorption; Isoquinolines; Neoplasm Proteins; Tetrahydroisoquinolines; Topoisomerase I Inhibitors; Topotecan | 2002 |
Ultrastructural localization of acridine orange binding to DNA of human breast cancer cells.
Topics: Acridines; Adult; Binding Sites; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; DNA, Neoplasm; Female; Humans; Middle Aged | 1977 |
Photocarcinogenesis by methoxypsoralen, neutral red and proflavine.
Topics: Acridines; Animals; Breast Neoplasms; Female; Methoxsalen; Mice; Neoplasms; Neutral Red; Phenazines; Proflavine; Sebaceous Gland Neoplasms; Skin; Thyroid Neoplasms; Ultraviolet Rays | 1979 |
[Results of therapeutic use of ledakrin in cancer-induced pleural effusion].
Topics: Acridines; Adult; Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Nitracrine; Pleural Effusion; Remission, Spontaneous | 1979 |
Acridine orange metachromasia for characterization of leukocytes in leukemia, lymphoma, and other neoplasms.
Topics: Acridines; Breast Neoplasms; Cell Nucleus; Cytoplasm; Fluorescent Dyes; Fluorometry; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mycosis Fungoides; Neoplasms; Photometry; Polycythemia Vera; Staining and Labeling | 1972 |
Elastase digestion of the amyloid-like substance surrounding mammary cancer and basal cell carcinoma of the skin.
Topics: Acridines; Aminosalicylic Acids; Amyloid; Breast Neoplasms; Carcinoma, Basal Cell; Congo Red; Female; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Pancreatic Elastase; Skin Neoplasms; Staining and Labeling; Tolonium Chloride | 1973 |
[Acridine orange-chromium fluoride and cytochemical control studies of carcinomas in cytological smear preparations].
Topics: Acridines; Adenocarcinoma, Papillary; Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Cytodiagnosis; Female; Gallbladder Neoplasms; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Microscopy, Fluorescence; Middle Aged; Staining and Labeling; Urogenital Neoplasms | 1965 |
Therapeutic efficacy of compound C-283 in patients with mammary carcinoma.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Dimethylamines; Drug Evaluation; Erythrocytes; Female; Humans; Injections, Intravenous; Kidney Function Tests; Leukocytes; Liver Function Tests; Nitro Compounds; Phlebitis; Remission, Spontaneous; Urine; Vomiting | 1973 |
[The significance of cytological examinations under fluorescence microscope for diagnosis and surgical treatment of maignant tumours. I].
Topics: Acridines; Breast Neoplasms; Colonic Neoplasms; Cytodiagnosis; Esophageal Neoplasms; Humans; Lung Neoplasms; Microscopy, Fluorescence; Neoplasms; Stomach Neoplasms | 1970 |